YWHAH

14-3-3 protein eta · Q04917 · YWHAH on Sugi Atlas →

203 patent compounds predicted against YWHAH, 110 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL29068286 SCHEMBL29068286 1.00 6/20
SCHEMBL30490432 SCHEMBL30490432 1.00 6/20
SCHEMBL30490434 SCHEMBL30490434 0.90 6/20
SCHEMBL30490436 SCHEMBL30490436 0.70 6/20
SCHEMBL30490429 SCHEMBL30490429 1.00 5/20
SCHEMBL30490431 SCHEMBL30490431 0.80 5/20
SCHEMBL30490428 SCHEMBL30490428 0.79 5/20
SCHEMBL22346544 SCHEMBL22346544 0.50 5/20
SCHEMBL30490435 SCHEMBL30490435 0.65 4/20
SCHEMBL4260289 SCHEMBL4260289 0.53 4/20
SCHEMBL30490433 SCHEMBL30490433 0.51 4/20
SCHEMBL4261606 SCHEMBL4261606 0.47 4/20
SCHEMBL8167666 SCHEMBL8167666 0.46 4/20
SCHEMBL4257381 SCHEMBL4257381 0.42 4/20
SCHEMBL23641029 SCHEMBL23641029 0.44 3/20
SCHEMBL8171636 SCHEMBL8171636 0.41 3/20
SCHEMBL2555312 SCHEMBL2555312 0.54 2/20
SCHEMBL4885587 SCHEMBL4885587 0.53 2/20
SCHEMBL4266132 SCHEMBL4266132 0.49 2/20
SCHEMBL12665133 SCHEMBL12665133 0.48 2/20

Clinical trials — most relevant to YWHAH by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study PHASE4COMPLETED
Reducing the Risk of Drug-Induced QT Interval Lengthening in Women PHASE4COMPLETED
Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment PHASE2COMPLETED
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer PHASE2COMPLETED
SCARFREE-001: Verteporfin for Scar Prevention PHASE2NOT_YET_RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer EARLY_PHASE1COMPLETED
Relationship of YWHAH Polymorphisms to Rheumatoid Arthritis Disease Severity nanCOMPLETED
IVM for Patients With Low Ovarian Response. Does it Improve IVFoutcomes and Does it Improve the Following IVF Cycle? nanUNKNOWN
Semen Analysis Changes in Covid-19 Positivepatients nanCOMPLETED
Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma nanCOMPLETED
Blood-based Biomarkers for the Prognosis of Sports Related Concussion nanCOMPLETED
Multi-Dimensional Genomic Dissection of Ring Chromosome 14 Syndrome nanACTIVE_NOT_RECRUITING
X-chromosome Inactivation, Epigenetics and the Transcriptome nanCOMPLETED
Family Blood Pressure Program - GenNet Network nanCOMPLETED
Cell Membrane Potential Regulates Spatial-Specific Mechanoptosis Resistance and Metastasis in Colorectal Cancer Via Mechanotransduction and the PVR/CD96 Axis nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients nanCOMPLETED
Identification of an Asthma Susceptibility Gene on 3P nanCOMPLETED
The Synergistic Effects of AIH and FES in Persons With MS nanACTIVE_NOT_RECRUITING
Heart Failure and a Preserved Ejection Fraction nanCOMPLETED
Family Blood Pressure Program - HyperGEN nanCOMPLETED
Immune Cell Response to Stimuli nanRECRUITING
Family Blood Pressure Program - SAPPHIRe Network nanCOMPLETED
Family Blood Pressure Program - GENOA nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Cardiopulmonary and Right Ventricular Function in Health and Disease nanUNKNOWN
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma nanUNKNOWN
Genomic Predictors of Recurrent Pregnancy Loss nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a YWHAH binder may also engage these)

ProteinNameSimilarity
P68509 1.000 P68509 →
YWHAG 14-3-3 protein gamma 1.000 landscape →
Q5RC20 1.000 Q5RC20 →
Q5ZLQ6 1.000 Q5ZLQ6 →
Q6PCG0 1.000 Q6PCG0 →
Q6PC29 1.000 Q6PC29 →
Q6UFZ3 1.000 Q6UFZ3 →
P35213 1.000 P35213 →
P68511 1.000 P68511 →
P68250 1.000 P68250 →
P61982 1.000 P61982 →
Q6UFZ8 1.000 Q6UFZ8 →
P68252 1.000 P68252 →
Q7T356 1.000 Q7T356 →
Q6UFZ9 1.000 Q6UFZ9 →
P48347 0.999 P48347 →
Q6NRY9 0.999 Q6NRY9 →
YWHAZ 14-3-3 protein zeta/delta 0.999 landscape →
Q5R651 0.999 Q5R651 →
YWHAQ 14-3-3 protein theta 0.999 landscape →
Q4R572 0.999 Q4R572 →
YWHAB 14-3-3 protein beta/alpha 0.999 landscape →
P68255 0.999 P68255 →
Q52M98 0.999 Q52M98 →
A4K2U9 0.999 A4K2U9 →
Q91896 0.999 Q91896 →
P42649 0.999 P42649 →
P68510 0.999 P68510 →
Q1HR36 0.999 Q1HR36 →
Q9CQV8 0.999 Q9CQV8 →